Close Menu

NEW YORK (GenomeWeb) – Belgian molecular diagnostics firm Biocartis reported today that its first-half 2016 revenues fell 7 percent year over year on lower collaboration revenues.

The firm reported total revenues of €6.1 million ($6.9 million) versus €6.6 million for the first half of 2015. Its product sales jumped 63 percent to €2.7 million from €1.7 million, due to a 314 percent year-over-jump increase in cartridge sales. Sales for its Idylla molecular diagnostics systems were down 21 percent to €988,000 from €1.2 million.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Oct
24

This webinar will tell the story of Versiti’s journey in transforming genetic testing from a manual to a digitized process. It will include detail on how the organization succeeded, pain points along the way, a novel approach to variant assessment, and future plans for the program.

Nov
14
Sponsored by
Qiagen

This webinar will discuss some of the issues laboratories face when transitioning to next-generation sequencing, and the key features to be considered for a successful implementation in routine testing.

Dec
02
Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.